
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Zylox-Tonbridge Medical Technology Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.04
16.52
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Zylox-Tonbridge Medical Technology Co Ltd hold over its rivals?
What risks and challenges
does Zylox-Tonbridge Medical Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Zylox-Tonbridge Medical Technology Co Ltd.
Provide an overview of the primary business activities
of Zylox-Tonbridge Medical Technology Co Ltd.
What unique competitive advantages
does Zylox-Tonbridge Medical Technology Co Ltd hold over its rivals?
What risks and challenges
does Zylox-Tonbridge Medical Technology Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide P/S
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide P/E
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide P/OCF
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide P/FCFE
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide P/B
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/S
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/GP
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/EBITDA
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/EBIT
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/OCF
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/FCFF
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide EV/IC
for Zylox-Tonbridge Medical Technology Co Ltd.
Show me price targets
for Zylox-Tonbridge Medical Technology Co Ltd made by professional analysts.
What are the Revenue projections
for Zylox-Tonbridge Medical Technology Co Ltd?
How accurate were the past Revenue estimates
for Zylox-Tonbridge Medical Technology Co Ltd?
What are the Net Income projections
for Zylox-Tonbridge Medical Technology Co Ltd?
How accurate were the past Net Income estimates
for Zylox-Tonbridge Medical Technology Co Ltd?
What are the EPS projections
for Zylox-Tonbridge Medical Technology Co Ltd?
How accurate were the past EPS estimates
for Zylox-Tonbridge Medical Technology Co Ltd?
What are the EBIT projections
for Zylox-Tonbridge Medical Technology Co Ltd?
How accurate were the past EBIT estimates
for Zylox-Tonbridge Medical Technology Co Ltd?
Compare the revenue forecasts
for Zylox-Tonbridge Medical Technology Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Zylox-Tonbridge Medical Technology Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Zylox-Tonbridge Medical Technology Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Zylox-Tonbridge Medical Technology Co Ltd compared to its peers.
Compare the P/E ratios
of Zylox-Tonbridge Medical Technology Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Zylox-Tonbridge Medical Technology Co Ltd with its peers.
Analyze the financial leverage
of Zylox-Tonbridge Medical Technology Co Ltd compared to its main competitors.
Show all profitability ratios
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide ROE
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide ROA
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide ROIC
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide ROCE
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Gross Margin
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Operating Margin
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Net Margin
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide FCF Margin
for Zylox-Tonbridge Medical Technology Co Ltd.
Show all solvency ratios
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide D/E Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide D/A Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Interest Coverage Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Altman Z-Score Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Quick Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Current Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
Provide Cash Ratio
for Zylox-Tonbridge Medical Technology Co Ltd.
What is the historical Revenue growth
over the last 5 years for Zylox-Tonbridge Medical Technology Co Ltd?
What is the historical Net Income growth
over the last 5 years for Zylox-Tonbridge Medical Technology Co Ltd?
What is the current Free Cash Flow
of Zylox-Tonbridge Medical Technology Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Zylox-Tonbridge Medical Technology Co Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CN |
![]() |
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
5.3B HKD | -179.8 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
226.5B USD | 22.6 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.2B USD | 58.4 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
146.4B USD | 36.1 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
139B USD | 24.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
112.5B USD | 14.1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
66B USD | 15.7 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
56.7B EUR | 16.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
41.7B USD | 23.5 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
288.7B CNY | 20.4 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.6B USD | 12.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CN |
![]() |
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Average EV/EBITDA:
24.4
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.6
|
12%
|
1.9 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
58.4
|
25%
|
2.3 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
36.1
|
20%
|
1.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
24.1
|
12%
|
2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
14.1
|
9%
|
1.6 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
15.7
|
12%
|
1.3 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
16.3
|
15%
|
1.1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
23.5
|
11%
|
2.1 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
20.4
|
18%
|
1.1 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
12.8
|
12%
|
1.1 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.